Incorporating real option value in valuing innovation: a way forward

PharmacoEconomics

10 July 2024 - Considerable progress has been made in defining and measuring the real option value of medical technologies. 

However, questions remain on how to estimate (1) real option value outside of life-extending oncology interventions; (2) the impact of real option value on costs and cost effectiveness; and (3) potential interactions between real option and other elements of value.

Read PharmacoEconomics article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Cancer , Medicine , US , Value , Innovation